Belimumab in Black patients with SLE

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2021年 / 3卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E550 / E550
页数：1
相关论文
共 50 条
  • [21] SLE Patients with No Organ Damage Might Benefit More from Belimumab Treatment
    Parodis, Ioannis
    Emamikia, Sharzad
    Gomez, Alvaro
    Chatzidionysiou, Katerina
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] Predicted Chronic Exposure and Dose Selection for Belimumab Administered Subcutaneously to SLE Patients
    Struemper, Herbert
    Roth, David
    Gordon, David
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S292 - S292
  • [23] Belimumab might retard SLE damage accrual
    Caroline Barranco
    Nature Reviews Rheumatology, 2016, 12 (4) : 194 - 194
  • [24] THE EFFICACY OF BELIMUMAB (BEL) AS A SPARING CORTICOSTEROID AGENCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Inoue, K.
    Misaki, K.
    Dobashi, N.
    Yabe, M.
    Mako, Y.
    Tarutani, Y.
    Imaizumi, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1343 - 1343
  • [25] BELIMUMAB ADD-ON THERAPY MOBILISES MEMORY B CELLS INTO THE CIRCULATION OF PATIENTS WITH SLE
    Arends, E. J.
    Zlei, M.
    Tipton, C. M.
    Osmani, Z.
    Kamerling, S.
    Rabelink, T.
    Sanz, I.
    Van Dongen, J. J. M.
    Van Kooten, C.
    Teng, Y. K. O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 585 - 585
  • [26] PHARMACOKINETICS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Sheikh, S. Z.
    Fox, N. L.
    Hammer, A. E.
    Struemper, H.
    Groark, J.
    Roth, D.
    Gordon, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 297 - 298
  • [27] An indirect comparison of intravenous and subcutaneous belimumab efficacy in patients with SLE and high disease activity
    Ramachandran, Sulabha
    Parks, Daniel
    Kurtinecz, Milena
    Roth, David A.
    Alfonso-Cristancho, Rafael
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (06) : 581 - 593
  • [28] THE COST-EFFECTIVENESS OF BELIMUMAB FOR THE TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN CHINA
    He, X.
    Lloyd, E.
    Asukai, Y.
    Chauhan, D.
    Tang, Z.
    Treur, M.
    VALUE IN HEALTH, 2022, 25 (12) : S123 - S123
  • [29] BELIMUMAB ADD-ON THERAPY MOBILIZES MEMORY B CELLS INTO CIRCULATION OF SLE PATIENTS
    Arends, E. J.
    Zlei, Mihaela
    Tipton, Christopher M.
    Osmani, Zgjim
    Kamerling, S. W. A.
    Rabelink, Ton
    Sanz, Ignacio
    Van Dongen, J. J. M.
    Van Kooten, Cees
    Teng, Y. K. O.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [30] Use of belimumab in real-world in Spain: a scoping review about characteristics of SLE patients
    Escalera, Carlos Rodriguez
    Guisado, Angela Maria Zurita
    Mateo, Francisco Javier
    Bahamontes-Rosa, Noemi
    Villanueva, Maria Jesus Garcia
    CLINICAL RHEUMATOLOGY, 2022, 41 (11) : 3373 - 3382
12345